Latest Insider Transactions at Myomo, Inc. (MYO)
This section provides a real-time view of insider transactions for Myomo, Inc. (MYO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYOMO, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYOMO, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2023
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+36.12%
|
-
|
|
Jun 28
2023
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+33.09%
|
-
|
|
Jun 28
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+24.99%
|
-
|
|
Jun 28
2023
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+29.51%
|
-
|
|
Jun 28
2023
|
Amy K. Knapp |
BUY
Grant, award, or other acquisition
|
Direct |
59,988
+42.97%
|
-
|
|
Jun 28
2023
|
Milton Mayo Morris |
BUY
Grant, award, or other acquisition
|
Direct |
59,988
+48.8%
|
-
|
|
Jun 28
2023
|
Thomas Aloysius Crowley Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
59,988
+50.0%
|
-
|
|
Jun 28
2023
|
Thomas F Kirk |
BUY
Grant, award, or other acquisition
|
Direct |
59,988
+40.95%
|
-
|
|
Jun 09
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
499
-0.81%
|
$0
$0.46 P/Share
|
|
Jun 08
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,105
-7.63%
|
$0
$0.46 P/Share
|
|
Jun 06
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-0.19%
|
$0
$0.55 P/Share
|
|
May 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-0.2%
|
$0
$0.55 P/Share
|
|
Apr 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
129
-0.19%
|
$0
$0.73 P/Share
|
|
Mar 08
2023
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+17.2%
|
-
|
|
Mar 08
2023
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+8.61%
|
-
|
|
Mar 08
2023
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+20.16%
|
-
|
|
Mar 08
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+3.29%
|
-
|
|
Mar 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.26%
|
$0
$0.62 P/Share
|
|
Feb 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-0.26%
|
$0
$0.49 P/Share
|
|
Jan 17
2023
|
Micah Mitchell Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
15,384
+19.18%
|
$0
$0.32 P/Share
|
|
Jan 17
2023
|
David A Henry Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
76,923
+31.99%
|
$0
$0.32 P/Share
|
|
Jan 17
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
307,692
+38.9%
|
$0
$0.32 P/Share
|
|
Jan 04
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
139
-0.27%
|
$0
$0.49 P/Share
|
|
Dec 05
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-0.25%
|
$0
$0.66 P/Share
|
|
Dec 01
2022
|
Thomas F Kirk |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
333
+1.24%
|
-
|
|
Nov 22
2022
|
David A Henry Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,000
+9.41%
|
$0
$0.55 P/Share
|
|
Nov 21
2022
|
Paul R Gudonis Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
333
+0.19%
|
-
|
|
Nov 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-0.25%
|
$125
$1.37 P/Share
|
|
Oct 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.25%
|
$128
$1.57 P/Share
|
|
Sep 06
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.25%
|
$128
$1.76 P/Share
|
|
Aug 05
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
7,141
-35.63%
|
$7,141
$1.71 P/Share
|
|
Aug 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
118
-0.23%
|
$118
$1.91 P/Share
|
|
Jul 05
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
127
-0.25%
|
$127
$1.64 P/Share
|
|
Jun 14
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
291
-100.0%
|
$291
$1.67 P/Share
|
|
Jun 13
2022
|
Micah Mitchell Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,846
-3.6%
|
$1,846
$1.79 P/Share
|
|
Jun 13
2022
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,417
-5.39%
|
$4,417
$1.8 P/Share
|
|
Jun 13
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
484
-0.93%
|
$484
$1.83 P/Share
|
|
Jun 10
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
6,000
-95.37%
|
$6,000
$1.97 P/Share
|
|
Jun 09
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
110
-1.72%
|
$220
$2.15 P/Share
|
|
Jun 08
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
3,000
-31.91%
|
$6,000
$2.15 P/Share
|
|
Jun 08
2022
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,500
+33.6%
|
-
|
|
Jun 08
2022
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+35.02%
|
-
|
|
Jun 08
2022
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+35.32%
|
-
|
|
Jun 08
2022
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+29.96%
|
-
|
|
Jun 06
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
3,500
-27.13%
|
$7,000
$2.29 P/Share
|
|
Jun 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-0.57%
|
$276
$2.31 P/Share
|
|
May 24
2022
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,394
-7.73%
|
$6,788
$2.06 P/Share
|
|
May 24
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,849
-10.58%
|
$5,698
$2.06 P/Share
|
|
May 20
2022
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,302
+7.64%
|
-
|
|
May 20
2022
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,297
+15.89%
|
-
|